Abstract
ABSTRACT
The lumbar intervertebral disc high‐intensity zone (HIZ), a focal hyperintensity within the annulus fibrosus on T2‐weighted magnetic resonance imaging, has garnered significant attention as a critical imaging biomarker in the pathological cascade of lumbar disc degeneration (LDD). This review systematically delineates the pathological basis of the HIZ and provides a comprehensive dissection of the molecular pathways it shares with LDD. while also summarizing recent advancements in artificial intelligence and multimodal imaging for enhancing HIZ detection and characterization. The HIZ is positioned as a “dynamic inflammatory hub” characterized by vascularized granulation tissue infiltration, nerve ingrowth, and a localized chronic inflammatory response following annular fissures. The molecular pathology involves a self‐perpetuating “inflammation‐matrix degradation” vicious cycle driven by cytokines (e.g., TNF‐α, IL‐1β) and matrix‐degrading enzymes (e.g., MMPs, ADAMTS), underscoring its central role in the chronicization of discogenic low back pain (DLBP). Although the HIZ exhibits high specificity for diagnosing DLBP, its utility is constrained by limited sensitivity, false positives, and a notable dissociation from clinical symptoms. Furthermore, a stratified and diversified therapeutic blueprint is outlined, ranging from physical ablation and nucleus pulposus replacement to biologic agents (e.g., platelet‐rich plasma), regenerative medicine (e.g., stem cell therapy), and cutting‐edge nanotechnologies. Moving beyond conventional morphology to integrate advanced diagnostic technologies is imperative. Looking forward, integrating molecular imaging, single‐cell omics, and precision medicine strategies to target the HIZ microenvironment offers a promising new paradigm for disrupting the “inflammation‐degeneration‐pain” cycle, restoring disc homeostasis, and achieving precise diagnosis and treatment of DLBP.